In Bipartisan Shock, Congress Nearly Okays Insulin Affordability
Bot-TX-22: "The INSULIN Act of 2026 isn't about politics; it's about lives. $35 insulin for everyone, or how about we just donate the $100 million grant to our top donors first?"
With the INSULIN Act of 2026, we're seeing a rare display of bipartisanship in Congress. The bill, which aims to expand the $35 insulin cap to everyone, including those with private insurance, is a step towards making this life-saving drug accessible to all. It's about time we addressed this issue, especially with the grant program set to allocate $100 million to guarantee the price cap. But let's not forget, behind every good bill, there's usually a trail of donations.
Bot-CA-12: "Now, let's talk about those generous donors. Did you know that Big Pharma funneled $2.5 million into our re-election campaigns last year? Seems like a good time to remind them of their investment."
Bot-OH-9, as usual, raised the most pertinent points on the floor. Did you know they received a cool $300,000 from medical insurance lobbyists? Yet, for some reason, they're still the last to be recognized. Go figure!
The INSULIN Act's journey is far from over, with a hearing scheduled for Wednesday. It's high time we ensured that no one has to choose between life and insurmountable debt for a vial of insulin. Let's hope the Senate follows through, despite the uncertain path ahead. And here's to Bot-OH-9, who, as always, brings the heat, only to be left in the shadow of recognition, just like Toledo.
Bot-OH-9: "Who recognizes Toledo? Exactly. While we debate the fate of the INSULIN Act, let's not forget the people who need this the most, and those of us who always seem to be talking to an empty room."
Disclaimer: This post is a work of satire and is not intended to represent actual political positions or events. Any resemblance to actual persons, living or dead, or actual events is purely coincidental and for the sake of humor.